A Systematic Review of the Role of Penile Rehabilitation in Prostate Cancer Patients Receiving Radiotherapy and Androgen Deprivation Therapy

被引:5
作者
Doherty, Wesley [1 ]
Bridge, Pete [2 ]
机构
[1] Christie Hosp NHS Trust, Radiotherapy Dept, Manchester, Lancs, England
[2] Univ Liverpool, Directorate Radiotherapy, Liverpool, Merseyside, England
关键词
Prostate; radiotherapy; erectile dysfunction; penile rehabilitation; ERECTILE FUNCTION IIEF; QUALITY-OF-LIFE; SILDENAFIL CITRATE; RADIATION-THERAPY; DOUBLE-BLIND; PHOSPHODIESTERASE-5; INHIBITORS; RADICAL RADIOTHERAPY; INTERNATIONAL INDEX; OPEN-LABEL; DYSFUNCTION;
D O I
10.1016/j.jmir.2018.09.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction/Background: Treatment-induced erectile dysfunction (ED) is a common side effect of radiotherapy and androgen deprivation therapy (ADT) that impacts on patient quality of life. Penile rehabilitation interventions including pharmacologic and physical therapies aim to reduce the impact of ED. Despite The National Institute for Health and Care Excellence guidelines recommending access to ED services, penile rehabilitation is not widely discussed or implemented. This systematic review aimed to appraise the evidence base for penile rehabilitation and identify evidence-based recommendations for practice. Methods: A systematic review of the evidence base was undertaken using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Scopus and Medline (EBSCO) databases were searched for articles relevant to penile rehabilitation interventions for prostate radiotherapy patients. Study quality was graded using the Oxford Levels of Evidence and the Scottish Intercollegiate Guidelines Network. Results: This study identified 19 articles on penile rehabilitation in prostate radiotherapy patients, consisting of eight randomized controlled trials, three systematic reviews, and eight case studies. Findings confirmed the value of early use of phosphodiesterase type 5 inhibitors. Discussion: Despite the range of available physical and pharmaceutical interventions, relevant research focussed solely on the use of phosphodiesterase type 5 inhibitors. Themes from the reviewed articles indicated that timing of intervention was important with early on-going dosage most useful. There was also an identified need for ongoing prophylactic use during ADT. Evidence, in general, was of low quality and based on quantitative data only. Conclusion: Additional research into the wider range of penile rehabilitation interventions is urgently required to ensure patients have access to those therapies that are most appropriate for them. A paradigm shift toward qualitative research in the field of penile rehabilitation for prostate cancer patients treated with radiotherapy and ADT may be of value in future studies.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [41] A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
    Lee, C. Ellen
    Leslie, William D.
    Lau, Y. K. James
    [J]. BMC CANCER, 2012, 12
  • [42] Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes
    Catikkas, Nezahat Muge
    Bahat, Zumrut
    Oren, Meryem Merve
    Bahat, Gulistan
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (08) : 1747 - 1759
  • [43] Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis
    Hinojosa-Gonzalez, David E.
    Zafar, Affan
    Saffati, Gal
    Kronstedt, Shane
    Zlatev, Dimitar V.
    Khera, Mohit
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (03) : 507 - 519
  • [44] Comparative Efficacy of Combined Radiotherapy, Systemic Therapy, and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-Analysis and Systematic Review
    Wang, Yuhan
    Gui, Huiming
    Wang, Juan
    Tian, Junqiang
    Wang, Hanzhang
    Liang, Chaozhao
    Hao, Zongyao
    Rodriguez, Ronald
    Wang, Zhiping
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [45] Androgen deprivation therapy as backbone therapy in the management of prostate cancer
    Merseburger, Axel S.
    Alcaraz, Antonio
    von Klot, Christoph A.
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 7263 - 7274
  • [46] The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis
    Bigaran, Ashley
    Zopf, Eva
    Gardner, Jason
    La Gerche, Andre
    Murphy, Declan G.
    Howden, Erin J.
    Baker, Michael K.
    Cormie, Prue
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 35 - 48
  • [47] Androgen deprivation therapy and depression in the prostate cancer patients: review of risk and pharmacological management
    Alwhaibi, Abdulrahman
    Alsanea, Sary
    Almadi, Bana
    Al-Sabhan, Jawza
    Alosaimi, Fahad D.
    [J]. AGING MALE, 2022, 25 (01) : 101 - 124
  • [48] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Kathrine Røe
    Lars TG Mikalsen
    Albert J van der Kogel
    Johan Bussink
    Heidi Lyng
    Anne H Ree
    Laure Marignol
    Dag R Olsen
    [J]. Radiation Oncology, 7
  • [49] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Roe, Kathrine
    Mikalsen, Lars T. G.
    van der Kogel, Albert J.
    Bussink, Johan
    Lyng, Heidi
    Ree, Anne H.
    Marignol, Laure
    Olsen, Dag R.
    [J]. RADIATION ONCOLOGY, 2012, 7
  • [50] Androgen deprivation therapy for prostate cancer: New developments
    Rabbani, F
    Fair, WR
    [J]. INFECTIONS IN UROLOGY, 1999, 12 (04): : 104 - +